Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication
Uveal melanoma (UM) is the most common primary intraocular tumour in adults. Local resection, radiation therapy, and enucleation are the current first-line, primary UM treatments. However, regardless of the treatment received, around 50% of UM patients will develop metastatic disease within five to...
Saved in:
Main Authors: | Ellie Swords (Author), Breandán N. Kennedy (Author), Valentina Tonelotto (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Darovasertib, a novel treatment for metastatic uveal melanoma
by: Lei Cao, et al.
Published: (2023) -
Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations
by: Montazeri K, et al.
Published: (2023) -
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
by: Ashley N. Anderson, et al.
Published: (2024) -
Prognostic impact of MALs and potential immunotherapy targets in uveal melanoma
by: Jing Yang, et al.
Published: (2024) -
Opportunities of diagnostic imaging in monitoring the radiosurgery treatment for uveal melanoma
by: T.M. Babkina, et al.
Published: (2019)